National Institute of Pharmaceuticals Education and Research (NIPER), Guwahati is committed to developing Personal Protective Equipment’s (PPEs) to avoid the spread of COVID-19.
NIPER director USN Murty informed that the institute signed MoU with the Hindustan Antibiotic Limited (HAL), for large scale industrial-grade manufacturing and commercialization of their 3D printed antimicrobial face-shields.
The institute has also filed both an Indian design patent and provisional patent at Indian Patent Office, New Delhi on their 3D printed antimicrobial face-shields.
NIPER-Guwahati has designed, developed and validated 3D-printed antimicrobial face-shield to control the spread of novel coronavirus.
It has carried out careful analyses of several resources for risk measurement and on how viruses spread through bare hands and other body cavities like oral, ophthalmic & olfactory, etc. (even though ear as well).
Some of the salient features of their developed 3D printed antimicrobial face-shields include, highly occlusive, transparent, easy-to-design, low cost, easy to wear, antimicrobial in nature, excellent chemical stability, non-fragile and easy to clean with the existing sanitizers or any alcoholic disinfectant.
In addition to this, the institute has designed and developed a 3D-printed multi-layer antimicrobial face mask to control the spread of novel coronavirus.
The first layer of this mask will be anti-bacterial casing, the second layer will be the sanitizing layer and reducing exposure of airborne particulates.
Finally, the third layer will be the medicinal layer to prevent extra microbial attacks, etc.
Finally, the institute has also developed and validated a 3D-printed hands-free multi-tasking object for opening or closing of the doors, windows, drawers (both vertical & horizontal), refrigerator handle, elevator buttons, laptop/desktop keyboards, including turning on/off switch buttons.
This product is very handy, user-friendly, non-fragile, and easy to clean with the existing sanitizers or any alcoholic disinfectant.